Thursday, September 12, 2002 2:25:11 PM
14:16 ET Teva Pharm gets summary judgment for invalidity of patent (TEVA) 67.45 +0.25: Announces that a U. S. District Court judge has granted TEVA's motion for summary judgment of invalidity finding a patent relating to the generic equivalent of ABT's Vicoprofen; the FDA has been informed of the judge's order and the co is hopeful that its ANDA will receive final approval shortly.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
